Abstract
Efficient and precise design of antimicrobial peptides (AMPs) is of great importance in the field of AMP development. Computing provides opportunities for peptide de novo design. In the present investigation, a new machine learning-based AMP prediction model, AP_Sin, was trained using 1160 AMP sequences and 1160 non-AMP sequences. The results showed that AP_Sin correctly classified 94.61% of AMPs on a comprehensive dataset, outperforming the mainstream and open-source models (Antimicrobial Peptide Scanner vr.2, iAMPpred and AMPlify) and being effective in identifying AMPs. In addition, a peptide sequence generator, AP_Gen, was devised based on the concept of recombining dominant amino acids and dipeptide compositions. After inputting the parameters of the 71 tridecapeptides from antimicrobial peptides database (APD3) into AP_Gen, a tridecapeptide bank consisting of de novo designed 17,496 tridecapeptide sequences were randomly generated, from which 2675 candidate AMP sequences were identified by AP_Sin. Chemical synthesis was performed on 180 randomly selected candidate AMP sequences, of which 18 showed high antimicrobial activities against a wide range of the tested pathogenic microorganisms, and 16 of which had a minimal inhibitory concentration of less than 10 μg/mL against at least one of the tested pathogenic microorganisms. The method established in this research accelerates the discovery of valuable candidate AMPs and provides a novel approach for de novo design of antimicrobial peptides.
Graphical Abstract
Similar content being viewed by others
Data Availability
The data used to support the findings of this study are available from the corresponding author upon request.
References
United Nations Environment Programme (2023) Bracing for Superbugs: Strengthening environmental action in the One Health response to antimicrobial resistance. Geneva. https://www.unep.org/resources/superbugs/environmental-action. Accessed 5 Mar 2023
Huemer M, Shambat SM, Brugger SD et al (2020) Antibiotic resistance and persistence—implications for human health and treatment perspectives. EMBO Rep 21(12):51034. https://doi.org/10.15252/embr.202051034
Hafeez AB, Jiang X, Bergen PJ et al (2021) Antimicrobial Peptides: an update on classifications and databases. Int J Mol Sci 22(21):11691. https://doi.org/10.3390/ijms222111691
Luo Y, Song Y (2021) Mechanism of antimicrobial peptides: antimicrobial, anti-inflammatory and antibiofilm activities. Int J Mol Sci 22(21):11401. https://doi.org/10.3390/ijms222111401
Mahlapuu M, Håkansson J, Ringstad L et al (2016) Antimicrobial peptides: an emerging category of therapeutic agents. Front Cell Infect Microbiol 6:194. https://doi.org/10.3389/fcimb.2016.00194
Deo S, Turton KL, Kainth T et al (2022) Strategies for improving antimicrobial peptide production. Biotechnol Adv 59:107968. https://doi.org/10.1016/j.biotechadv.2022.107968
Van Oort CM, Ferrell JB, Remington JM et al (2021) AMPGAN v2: machine learning-guided design of antimicrobial peptides. J Chem Inf Model 61(5):2198–2207. https://doi.org/10.1021/acs.jcim.0c01441
Zhang J, Yang L, Tian Z et al (2021) Large-scale screening of antifungal peptides based on quantitative structure-activity relationship. ACS Med Chem Lett 13(1):99–104. https://doi.org/10.1021/acsmedchemlett.1c00556
Wang C, Garlick S, Zloh M (2021) Deep learning for novel antimicrobial peptide design. Biomolecules 11(3):471. https://doi.org/10.3390/biom11030471
Zhang H, Saravanan KM, Wei Y et al (2023) Deep learning-based bioactive therapeutic peptide generation and screening. J Chem Inf Model 63(3):835–845. https://doi.org/10.1021/acs.jcim.2c01485
Sartor RC, Noshay J, Springer NM et al (2019) Identification of the expressome by machine learning on omics data. Proc Natl Acad Sci USA 116(36):18119–18125. https://doi.org/10.1073/pnas.1813645116
Tyanova S, Temu T, Sinitcyn P et al (2016) The Perseus computational platform for comprehensive analysis of (prote)omics data. Nat Methods 13(9):731–740. https://doi.org/10.1038/nmeth.3901
Svenson J, Molchanova N, Schroeder CI (2020) Antimicrobial peptide mimics for clinical use: does size matter? Front Immunol 13:915368. https://doi.org/10.3389/fimmu.2022.915368
Li R, Wu J, He F et al (2023) Rational design, synthesis, antifungal evaluation and docking studies of antifungal peptide CGA-N12 analogues based on the target CtKRE9. Bioorg Chem 132:106355. https://doi.org/10.1016/j.bioorg.2023.106355
Veltri D, Kamath U, Shehu A (2018) Deep learning improves antimicrobial peptide recognition. Bioinformatics 34(16):2740–2747. https://doi.org/10.1093/bioinformatics/bty179
Meher PK, Sahu TK, Saini V et al (2017) Predicting antimicrobial peptides with improved accuracy by incorporating the compositional, physico-chemical and structural features into Chou’s general PseAAC. Sci Rep 7(1):42362. https://doi.org/10.1038/srep42362
Li C, Sutherland D, Hammond SA et al (2020) AMPlify: attentive deep learning model for discovery of novel antimicrobial peptides effective against WHO priority pathogens. BMC Genomics 23(1):77. https://doi.org/10.1186/s12864-022-08310-4
Huang J, Xu Y, Xue Y et al (2023) Identification of potent antimicrobial peptides via a machine-learning pipeline that mines the entire space of peptide sequences. Nat Biomed Eng 7(6):797–810. https://doi.org/10.1038/s41551-022-00991-2
Das P, Sercu T, Wadhawan K et al (2021) Accelerated antimicrobial discovery via deep generative models and molecular dynamics simulations. Nat Biomed Eng 5(6):613–623. https://doi.org/10.1038/s41551-021-00689-x
Cao Q, Ge C, Wang X et al (2023) Designing antimicrobial peptides using deep learning and molecular dynamic simulations. Brief Bioinform 24(2):bbad058. https://doi.org/10.1093/bib/bbad058
Bagherian M, Sabeti E, Wang K et al (2021) Machine learning approaches and databases for prediction of drug-target interaction: a survey paper. Brief Bioinform 22(1):247–269. https://doi.org/10.1093/bib/bbz157
Javeed A, Dallora A, Berglund J et al (2023) Machine learning for dementia prediction: a systematic review and future research directions. J Med Syst 47(1):17. https://doi.org/10.1007/s10916-023-01906-7
Rustam F, Reshi AA, Mehmood A et al (2020) COVID-19 future forecasting using supervised machine learning models. IEEE Access 8:101489–101499. https://doi.org/10.1109/access.2020.2997311
Uddin S, Khan A, Hossain ME et al (2019) Comparing different supervised machine learning algorithms for disease prediction. BMC Med Inform Decis Mak 19(1):281. https://doi.org/10.1186/s12911-019-1004-8
Topaz M, Murga L, Gaddis KM et al (2019) Mining fall-related information in clinical notes: comparison of rule-based and novel word embedding-based machine learning approaches. J Biomed Inform 90:103103. https://doi.org/10.1016/j.jbi.2019.103103
Bui H-L, Tran Q-C (2021) A new approach for tuning control rule based on hedge algebras theory and application in structural vibration control. J Vib Control 27(23–24):2686–2700. https://doi.org/10.1177/1077546320964307
Dandea V, Grigoras G (2023) Expert system integrating rule-based reasoning to voltage control in photovoltaic-systems-rich low voltage electric distribution networks: a review and results of a case study. Appl Sci 13(10):6158. https://doi.org/10.3390/app13106158
Abdel Monaim SAH, Jad YE, El-Faham A et al (2018) Teixobactin as a scaffold for unlimited new antimicrobial peptides: SAR study. Bioorgan Med Chem 26(10):2788–2796. https://doi.org/10.1016/j.bmc.2017.09.040
Porto WF, Irazazabal L, Alves ESF et al (2018) In silico optimization of a guava antimicrobial peptide enables combinatorial exploration for peptide design. Nat Commun 9(1):1490. https://doi.org/10.1038/s41467-018-03746-3
Funding
This work was supported by the Natural Science Foundation of Henan Province (2323000421165); the Innovative Funds Plan of Henan University of Technology (2020ZKCJ23).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of Interest
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Yin, K., Xu, W., Ren, S. et al. Machine Learning Accelerates De Novo Design of Antimicrobial Peptides. Interdiscip Sci Comput Life Sci (2024). https://doi.org/10.1007/s12539-024-00612-3
Received:
Revised:
Accepted:
Published:
DOI: https://doi.org/10.1007/s12539-024-00612-3